Fuse Medical, Inc.
FZMD
$0.062
-$0.0279-31.03%
| 06/30/2023 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 25.42% | -18.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.42% | -18.44% | |||
| Cost of Revenue | 30.80% | -48.59% | |||
| Gross Profit | 23.18% | 7.77% | |||
| SG&A Expenses | 4.04% | -7.57% | |||
| Depreciation & Amortization | -2.10% | 137.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.53% | -22.77% | |||
| Operating Income | 322.77% | 66.06% | |||
| Income Before Tax | 241.29% | -106.25% | |||
| Income Tax Expenses | 28.57% | -12.50% | |||
| Earnings from Continuing Operations | 234.68% | -106.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 234.68% | -106.42% | |||
| EBIT | 322.77% | 66.06% | |||
| EBITDA | 403.78% | 70.85% | |||
| EPS Basic | 237.50% | -106.32% | |||
| Normalized Basic EPS | 240.00% | 58.33% | |||
| EPS Diluted | 221.88% | -108.99% | |||
| Normalized Diluted EPS | 225.00% | 41.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 10.96% | -30.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
